WeissLaw LLP, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Duff & Phelps Corporation (“D&P” or the “Company”) (NasdaqGS: DUF) arising from its agreement for D&P to be acquired by The Carlyle Group, Stone Point Capital LLC, Pictet & Cie and Edmond de Rothschild Group (the “Private Equity Firms”), in a transaction valued at approximately $665.5 million. Under the terms of the proposed transaction D&P shareholders will receive $15.55 in cash for each D&P share they own. This price is below the target price set by certain securities analysts.
WeissLaw LLP is investigating whether D&P’s Board acted in the best interests of its public shareholders by actively shopping the Company to maximize shareholder value for D&P’s public shareholders, prior to entering into the proposed transaction with the Private Equity Firms. If you own D&P shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Joshua M. Rubin either by email at firstname.lastname@example.org or by telephone at (888) 593-4771.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar outcome.